What's new in pediatric dermatology?: Part II. Treatment

Journal of the American Academy of Dermatology

Volumn 68, Issue 6, 2013, Pages 899.e1-899.e11

  Pride, Howard B ^a   Tollefson, Megha ^b   Silverman, Robert ^c  

^a GEISINGER MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acne; atopic dermatitis; eczema herpeticum; general anesthesia; hemangioma; herpes simplex; isotretinoin; lymphangioma; neonatal herpes simplex; pediatric dermatology; propranolol; rapamycin; texting; tinea capitis; vascular malformation

Indexed keywords

ABATACEPT; ACICLOVIR; ATENOLOL; CIDOFOVIR; ETANERCEPT; GRISEOFULVIN; IBUTAMOREN; ISOTRETINOIN; NADOLOL; OMALIZUMAB; PLACEBO; PROPRANOLOL; RAPAMYCIN; SILDENAFIL; TERBINAFINE;

ACNE; ASTHMA; ASTIGMATISM; ATOPIC DERMATITIS; ATTENTION DEFICIT DISORDER; BLUE RUBBER BLEB NEVUS; BULLOUS PEMPHIGOID; CAPILLARY HEMANGIOMA; COMPUTER ASSISTED TOMOGRAPHY; DERMATOMYOSITIS; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; EPIDERMOLYSIS BULLOSA ACQUISITA; FOLLOW UP; GENERAL ANESTHESIA; HEALTH CARE QUALITY; HEMANGIOENDOTHELIOMA; HEMANGIOFIBROMA; HEMIPARESIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; HYPOTENSION; JUVENILE RHEUMATOID ARTHRITIS; LEARNING DISORDER; LYMPHATIC MALFORMATION; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR DEPRESSION; MULTICENTER STUDY (TOPIC); NIGHTMARE; PATIENT CARE; PEMPHIGUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIASIS; PSORIASIS AREA AND SEVERITY INDEX; PULSED DYE LASER; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SOCIAL MEDIA; SUICIDAL IDEATION; SUICIDE ATTEMPT; SYSTEMATIC REVIEW; SYSTEMIC THERAPY; TEXT MESSAGING; TINEA CAPITIS; TRICHOPHYTON TONSURANS; TUBEROUS SCLEROSIS; ULCERATIVE COLITIS; VASCULAR LESION; VASCULAR TUMOR; VERRUCA VULGARIS; WOUND CARE;

EID: 84877812419     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.03.002     Document Type: Review

References (111)

1. J.T. Huang, M. Abrams, B. Tlougan, A. Rademaker, and A.S. Paller Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity Pediatrics 123 2009 e808 e814
2. T.S. Dabade, D.M. Davis, D.A. Wetter, J.L. Hand, M.T. McEvoy, and M.R. Pittelkow Wet dressing therapy in conjunction with topical corticosteroids is effective for rapid control of severe pediatric atopic dermatitis: experience with 218 patients over 30 years at Mayo Clinic J Am Acad Dermatol 67 2012 100 106
3. D. Thaci, S. Reitamo, M.A. Gonzalez Ensenat, C. Moss, V. Boccaletti, and T. Cainelli Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study Br J Dermatol 159 2008 1348 1356
4. E. Healy, A. Bentley, C. Fidler, and C. Chambers Cost-effectiveness of tacrolimus ointment in adults and children with moderate and severe atopic dermatitis: twice-weekly maintenance treatment vs. standard twice-daily reactive treatment of exacerbations from a third party payer (U.K. National Health Service) perspective Br J Dermatol 164 2011 387 395
5. J. Schmitt, L. von Kobyletzki, A. Svensson, and C. Apfelbacher Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials Br J Dermatol 164 2011 415 428
6. C. Leaute-Labreze, E. Dumas de la Roque, T. Hubiche, F. Boralevi, J.B. Thambo, and A. Taieb Propranolol for severe hemangiomas of infancy N Engl J Med 358 2008 2649 2651
7. V. Sans, E.D. de la Roque, J. Berge, N. Grenier, F. Boralevi, and J. Mazereeuw-Hautier Propranolol for severe infantile hemangiomas: follow-up report Pediatrics 124 2009 e423 e431
8. A. Zvulunov, C. McCuaig, I.J. Frieden, A.J. Mancini, K.B. Puttgen, and M. Dohil Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study Pediatr Dermatol 28 2011 94 98
9. Annabel M, Shanna B, Gerard L, Soizick PL, Denis H, Allan E. Lack of effect of propranolol in the treatment of lymphangioma in two children. Pediatr Dermatol 2012 Sep 25. doi: 10.1111/j.1525-1470.2012.01864.x [Epub ahead of print].
10. Y.E. Chiu, B.A. Drolet, F. Blei, M. Carcao, J. Fangusaro, and M.E. Kelly Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon Pediatr Blood Cancer 59 2012 934 938
11. C.J. Price, C. Lattouf, B. Baum, M. McLeod, L.A. Schachner, and A.M. Duarte Propranolol vs corticosteroids for infantile hemangiomas: a multicenter retrospective analysis Arch Dermatol 147 2011 1371 1376
12. M. Hogeling, S. Adams, and O. Wargon A randomized controlled trial of propranolol for infantile hemangiomas Pediatrics 128 2011 e259 e266
13. T.G. Missoi, G.T. Lueder, K. Gilbertson, and S.J. Bayliss Oral propranolol for treatment of periocular infantile hemangiomas Arch Ophthalmol 129 2011 899 903
14. F. Thoumazet, C. Leaute-Labreze, J. Colin, and B. Mortemousque Efficacy of systemic propranolol for severe infantile haemangioma of the orbit and eyelid: a case study of eight patients Br J Ophthalmol 96 2012 370 374
15. I. Claerhout, M. Buijsrogge, P. Delbeke, S. Walraedt, S. De Schepper, and B. De Moerloose The use of propranolol in the treatment of periocular infantile haemangiomas: a review Br J Ophthalmol 95 2011 1199 1202
16. K.W. Rosbe, K.Y. Suh, A.K. Meyer, S.M. Maguiness, and I.J. Frieden Propranolol in the management of airway infantile hemangiomas Arch Otolaryngol Head Neck Surg 136 2010 658 665
17. S. Peridis, G. Pilgrim, I. Athanasopoulos, and K. Parpounas A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas Int J Pediatr Otorhinolaryngol 75 2011 455 460
18. N. Leboulanger, P. Fayoux, N. Teissier, A. Cox, T. Van Den Abbeele, and L. Carrabin Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: a preliminary retrospective study of French experience Int J Pediatr Otorhinolaryngol 74 2010 1254 1257
19. I. Yeh, A.L. Bruckner, R. Sanchez, M.R. Jeng, B.D. Newell, and I.J. Frieden Diffuse infantile hepatic hemangiomas: a report of four cases successfully managed with medical therapy Pediatr Dermatol 28 2011 267 275
20. S.T. Tan, T. Itinteang, and P. Leadbitter Low-dose propranolol for multiple hepatic and cutaneous hemangiomas with deranged liver function Pediatrics 127 2011 e772 e776
21. J. Mazereeuw-Hautier, P.H. Hoeger, S. Benlahrech, A. Ammour, P. Broue, and J. Vial Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis J Pediatr 157 2010 340 342
22. M. Saint-Jean, C. Leaute-Labreze, J. Mazereeuw-Hautier, N. Bodak, D. Hamel-Teillac, and I. Kupfer-Bessaguet Propranolol for treatment of ulcerated infantile hemangiomas J Am Acad Dermatol 64 2011 827 832
23. D.J. Hermans, I.M. van Beynum, L.J. Schultze Kool, P.C. van de Kerkhof, M.H. Wijnen, and C.J. van der Vleuten Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls J Am Acad Dermatol 64 2011 833 838
24. D. Metry, I.J. Frieden, C. Hess, D. Siegel, M. Maheshwari, and E. Baselga Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants Pediatr Dermatol 30 2013 71 89
25. S. Hernandez-Martin, J.C. Lopez-Gutierrez, S. Lopez-Fernandez, M. Ramirez, M. Miguel, and J. Coya Brain perfusion SPECT in patients with PHACES syndrome under propranolol treatment Eur J Pediatr Surg 22 2012 54 59
26. C.H. Storch, and P.H. Hoeger Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action Br J Dermatol 163 2010 269 274
27. B.A. Drolet, P.C. Frommelt, S.L. Chamlin, A. Haggstrom, N.M. Bauman, and Y.E. Chiu Initiation and use of propranolol for infantile hemangioma: report of a consensus conference Pediatrics 131 2013 128 140
28. L.P. Lawley, E. Siegfried, and J.L. Todd Propranolol treatment for hemangioma of infancy: risks and recommendations Pediatr Dermatol 26 2009 610 614
29. K.E. Holland, I.J. Frieden, P.C. Frommelt, A.J. Mancini, D. Wyatt, and B.A. Drolet Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma Arch Dermatol 146 2010 775 778
30. M. de Graaf, J.M. Breur, M.F. Raphael, M. Vos, C.C. Breugem, and S.G. Pasmans Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants J Am Acad Dermatol 65 2011 320 327
31. C.J. Schupp, J.B. Kleber, P. Gunther, and S. Holland-Cunz Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome Pediatr Dermatol 28 2011 640 644
32. T.S. Chen, L.F. Eichenfield, and S.F. Friedlander Infantile hemangiomas: an update on pathogenesis and therapy Pediatrics 131 2013 99 108
33. L. Bagazgoitia, A. Hernandez-Martin, and A. Torrelo Recurrence of infantile hemangiomas treated with propranolol Pediatr Dermatol 28 2011 658 662
34. M.F. Raphael, M. de Graaf, C.C. Breugem, S.G. Pasmans, and J.M. Breur Atenolol: a promising alternative to propranolol for the treatment of hemangiomas J Am Acad Dermatol 65 2011 420 421
35. E. Pope, A. Chakkittakandiyil, I. Lara-Corrales, E. Maki, and M. Weinstein Expanding the therapeutic repertoire of infantile haemangiomas: cohort-blinded study of oral nadolol compared with propranolol Br J Dermatol 168 2013 222 224
36. E. Pope, and A. Chakkittakandiyil Topical timolol gel for infantile hemangiomas: a pilot study Arch Dermatol 146 2010 564 565
37. A. Chakkittakandiyil, R. Phillips, I.J. Frieden, E. Siegfried, I. Lara-Corrales, and J. Lam Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study Pediatr Dermatol 29 2012 28 31
38. M. Moehrle, C. Leaute-Labreze, V. Schmidt, M. Rocken, C.F. Poets, and R. Goelz Topical timolol for small hemangiomas of infancy Pediatr Dermatol 30 2013 245 249
39. M.M. Mutizwa, D.R. Berk, and M.J. Anadkat Treatment of facial angiofibromas with topical application of oral rapamycin solution (1mgmL(-1)) in two patients with tuberous sclerosis Br J Dermatol 165 2011 922 923
40. A.K. Haemel, A.L. O'Brian, and J.M. Teng Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis Arch Dermatol 146 2010 715 718
41. H. Yuksekkaya, O. Ozbek, M. Keser, and H. Toy Blue rubber bleb nevus syndrome: successful treatment with sirolimus Pediatrics 129 2012 e1080 e1084
42. A.M. Hammill, M. Wentzel, A. Gupta, S. Nelson, A. Lucky, and R. Elluru Sirolimus for the treatment of complicated vascular anomalies in children Pediatr Blood Cancer 57 2011 1018 1024
43. G.L. Swetman, D.R. Berk, S.S. Vasanawala, J.A. Feinstein, A.T. Lane, and A.L. Bruckner Sildenafil for severe lymphatic malformations N Engl J Med 366 2012 384 386
44. A.M. Tremaine, J. Armstrong, Y.C. Huang, L. Elkeeb, A. Ortiz, and R. Harris Enhanced port-wine stain lightening achieved with combined treatment of selective photothermolysis and imiquimod J Am Acad Dermatol 66 2012 634 641
45. W. Jia, V. Sun, N. Tran, B. Choi, S.W. Liu, and M.C. Mihm Jr. Long-term blood vessel removal with combined laser and topical rapamycin antiangiogenic therapy: implications for effective port wine stain treatment Lasers Surg Med 42 2010 105 112
46. A.S. Paller, E.C. Siegfried, R.G. Langley, A.B. Gottlieb, D. Pariser, and I. Landells Etanercept treatment for children and adolescents with plaque psoriasis N Engl J Med 358 2008 241 251
47. E.C. Siegfried, L.F. Eichenfield, A.S. Paller, D. Pariser, K. Creamer, and G. Kricorian Intermittent etanercept therapy in pediatric patients with psoriasis J Am Acad Dermatol 63 2010 769 774
48. A.S. Paller, E.C. Siegfried, L.F. Eichenfield, D. Pariser, R.G. Langley, and K. Creamer Long-term etanercept in pediatric patients with plaque psoriasis J Am Acad Dermatol 63 2010 762 768
49. M.J. Perman, D.J. Lovell, L.A. Denson, M.K. Farrell, and A.W. Lucky Five cases of anti-tumor necrosis factor alpha-induced psoriasis presenting with severe scalp involvement in children Pediatr Dermatol 29 2012 454 459
50. G. Hiremath, L. Duffy, and I. Leibowitz Infliximab-induced psoriasis in children with inflammatory bowel disease J Pediatr Gastroenterol Nutr 52 2011 230 232
51. McKinley SK, Huang JT, Tan J, Kroshinsky D, Gellis S. A case of recalcitrant epidermolysis bullosa acquisita responsive to rituximab therapy. Pediatr Dermatol 2012 Oct 29. doi: 10.1111/pde.12006 [Epub ahead of print].
52. H.H. Kong, N.S. Prose, R.E. Ware, and R.P. Hall Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab) Pediatr Dermatol 22 2005 461 464
53. E. Schmidt, E.B. Brocker, and M. Goebeler Rituximab in treatment-resistant autoimmune blistering skin disorders Clin Rev Allergy Immunol 34 2008 56 64
54. Y.E. Chiu, and D.O. Co Juvenile dermatomyositis: immunopathogenesis, role of myositis-specific autoantibodies, and review of rituximab use Pediatr Dermatol 28 2011 357 367
55. B. Arabshahi, R.A. Silverman, O.Y. Jones, and L.G. Rider Abatacept and sodium thiosulfate for treatment of recalcitrant juvenile dermatomyositis complicated by ulceration and calcinosis J Pediatr 160 2012 520 522
56. Kim DH, Park KY, Kim BJ, Kim MN, Mun SK. Anti-immunoglobulin E in the treatment of refractory atopic dermatitis. Clin Exp Dermatol 2012 Oct 22 doi: 10.1111/j.1365-2230.2012.04438.x [Epub ahead of print].
57. S. Rizzi, L.B. Carter, C. Ori, and V. Jevtovic-Todorovic Clinical anesthesia causes permanent damage to the fetal guinea pig brain Brain Pathol 18 2008 198 210
58. X. Zou, T.A. Patterson, R.L. Divine, N. Sadovova, X. Zhang, and J.P. Hanig Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain Int J Dev Neurosci 27 2009 727 731
59. W. Slikker Jr., X. Zou, C.E. Hotchkiss, R.L. Divine, N. Sadovova, and N.C. Twaddle Ketamine-induced neuronal cell death in the perinatal rhesus monkey Toxicol Sci 98 2007 145 158
60. R.T. Wilder, R.P. Flick, J. Sprung, S.K. Katusic, W.J. Barbaresi, and C. Mickelson Early exposure to anesthesia and learning disabilities in a population-based birth cohort Anesthesiology 110 2009 796 804
61. T.G. Hansen, J.K. Pedersen, S.W. Henneberg, D.A. Pedersen, J.C. Murray, and N.S. Morton Academic performance in adolescence after inguinal hernia repair in infancy: a nationwide cohort study Anesthesiology 114 2011 1076 1085
62. C. DiMaggio, L.S. Sun, and G. Li Early childhood exposure to anesthesia and risk of developmental and behavioral disorders in a sibling birth cohort Anesth Analg 113 2011 1143 1151
63. J. Sprung, R.P. Flick, R.T. Wilder, S.K. Katusic, T.L. Pike, and M. Dingli Anesthesia for cesarean delivery and learning disabilities in a population-based birth cohort Anesthesiology 111 2009 302 310
64. R.P. Flick, S.K. Katusic, R.C. Colligan, R.T. Wilder, R.G. Voigt, and M.D. Olson Cognitive and behavioral outcomes after early exposure to anesthesia and surgery Pediatrics 128 2011 e1053 e1061
65. C. Ing, C. DiMaggio, A. Whitehouse, M.K. Hegarty, J. Brady, and B.S. von Ungern-Sternberg Long-term differences in language and cognitive function after childhood exposure to anesthesia Pediatrics 130 2012 e476 e485
66. D.J. Korczak, and B.I. Goldstein Childhood onset major depressive disorder: course of illness and psychiatric comorbidity in a community sample J Pediatr 155 2009 118 123
67. J.A. Halvorsen, R.S. Stern, F. Dalgard, M. Thoresen, E. Bjertness, and L. Lien Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: a population-based study J Invest Dermatol 131 2011 363 370
68. T. Ergun, D. Seckin, N. Ozaydin, Ö. Bakar, A. Comert, and N. Atsu Isotretinoin has no negative effect on attention, executive function and mood J Eur Acad Dermatol Venereol 26 2012 431 439
69. E.J. McGrath, C.R. Lovell, F. Gillison, A. Darvay, J.R. Hickey, and S.M. Skevington A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms Br J Dermatol 163 2010 1323 1329
70. Y. Kaymak, E. Taner, and Y. Taner Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents Int J Dermatol 48 2009 41 46
71. K.E. Bozdag, S. Gulseren, F. Guven, and B. Cam Evaluation of depressive symptoms in acne patients treated with isotretinoin J Dermatolog Treat 20 2009 293 296
72. L.M. Rehn, E. Meririnne, J. Hook-Nikanne, E. Isometsa, and M. Henriksson Depressive symptoms and suicidal ideation during isotretinoin treatment: a 12-week follow-up study of male Finnish military conscripts J Eur Acad Dermatol Venereol 23 2009 1294 1297
73. M. Rademaker Adverse effects of isotretinoin: a retrospective review of 1743 patients started on isotretinoin Australas J Dermatol 51 2010 248 253
74. L.C. Schaffer, C.B. Schaffer, S. Hunter, and A. Miller Psychiatric reactions to isotretinoin in patients with bipolar disorder J Affect Disord 122 2010 306 308
75. A. Sundstrom, L. Alfredsson, G. Sjolin-Forsberg, B. Gerden, U. Bergman, and J. Jokinen Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study BMJ 341 2010 5812
76. S.M. Schleicher Oral isotretinoin and inflammatory bowel disease J Am Acad Dermatol 13 1985 834 835
77. S.D. Crockett, A. Gulati, R.S. Sandler, and M.D. Kappelman A causal association between isotretinoin and inflammatory bowel disease has yet to be established Am J Gastroenterol 104 2009 2387 2393
78. C.N. Bernstein, Z. Nugent, T. Longobardi, and J.F. Blanchard Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study Am J Gastroenterol 104 2009 2774 2778
79. S.D. Crockett, C.Q. Porter, C.F. Martin, R.S. Sandler, and M.D. Kappelman Isotretinoin use and the risk of inflammatory bowel disease: a case-control study Am J Gastroenterol 105 2010 1986 1993
80. C.M. Popescu, and R. Popescu Isotretinoin therapy and inflammatory bowel disease Arch Dermatol 147 2011 724 729
81. D.J. Margolis, M. Fanelli, O. Hoffstad, and J.D. Lewis Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease Am J Gastroenterol 105 2010 2610 2616
82. B.E. Elewski, H.W. Cáceres, L. DeLeon, S. El Shimy, J.A. Hunter, and N. Korotkiy Terbinafine hydrochloride oral granules versus oral griseofulvin suspension in children with tinea capitis: results of two randomized, investigator-blinded, multicenter, international, controlled trials J Am Acad Dermatol 59 2008 41 54
83. S.F. Friedlander, R. Aly, B. Krafchik, J. Blumer, P. Honig, and D. Stewart Terbinafine in the treatment of Trichophyton tinea capitis: a randomized, double-blind, parallel-group, duration-finding study Pediatrics 109 2002 602 607
84. S. Deng, H. Hu, P. Abliz, Z. Wan, A. Wang, and W. Cheng A random comparative study of terbinafine versus griseofulvin in patients with tinea capitis in western china Mycopathologia 172 2011 365 372
85. A.K. Gupta, and C. Drummond-Main Meta-analysis of randomized, controlled trials comparing particular doses of griseofulvin and terbinafine for the treatment of tinea capitis Pediatr Dermatol 30 2013 1 6
86. C. Grover, P. Arora, and V. Manchanda Comparative evaluation of griseofulvin, terbinafine and fluconazole in the treatment of tinea capitis Int J Dermatol 51 2012 455 458
87. C. Chen, L.H. Koch, J.E. Dice, K.K. Dempsey, A.B. Moskowitz, and M.L. Barnes-Eley A randomized, double-blind study comparing the efficacy of selenium sulfide shampoo 1% and ciclopirox shampoo 1% as adjunctive treatments for tinea capitis in children Pediatr Dermatol 27 2010 459 462
88. P.L. Aronson, A.C. Yan, M.K. Mittal, Z. Mohamad, and S.S. Shah Delayed acyclovir and outcomes of children hospitalized with eczema herpeticum Pediatrics 128 2011 1161 1167
89. S.S. Shah, P.L. Aronson, Z. Mohamad, and S.A. Lorch Delayed acyclovir therapy and death among neonates with herpes simplex virus infection Pediatrics 128 2011 1153 1160
90. D.W. Kimberlin, R.J. Whitley, W. Wan, D.A. Powell, G. Storch, and A. Ahmed Oral acyclovir suppression and neurodevelopment after neonatal herpes N Engl J Med 365 2011 1284 1292
91. H.H. Kralund, S. Broesby-Olsen, C. Bistrup, and H.F. Lorentzen Substantial effect of topical cidofovir 1% on recalcitrant warts in a renal-transplanted adolescent: a case report Transplantation 91 2011 e52 e54
92. S. Field, A.D. Irvine, and B. Kirby The treatment of viral warts with topical cidofovir 1%: our experience of seven paediatric patients Br J Dermatol 160 2009 223 224
93. K.H. Kim, T.D. Horn, J. Pharis, J. Kincannon, R. Jones, and K. O'Bryan Phase 1 clinical trial of intralesional injection of candida antigen for the treatment of warts Arch Dermatol 146 2010 1431 1433
94. L.L. Enns, and M.S. Evans Intralesional immunotherapy with Candida antigen for the treatment of molluscum contagiosum in children Pediatr Dermatol 28 2011 254 258
95. Cellular Telephone Industry Association web site. U.S. wireless quick facts. Available from: http://www.ctia.org/advocacy/research/index.cfm/AID/ 10323. Accessed January 31, 2013.
96. C.R. Ahlers-Schmidt, A. Chesser, T. Hart, A. Paschal, T. Nguyen, and R.R. Wittler Text messaging immunization reminders: feasibility of implementation with low-income parents Prev Med 50 2010 306 307
97. A. Boker, H.J. Feetham, A. Armstrong, P. Purcell, and H. Jacobe Do automated text messages increase adherence to acne therapy? Results of a randomized, controlled trial J Am Acad Dermatol 67 2012 1136 1142
98. T. Horvath, H. Azman, G.E. Kennedy, and G.W. Rutherford Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection Cochrane Database Syst Rev 3 2012 009756
99. S. Krishna, S.A. Boren, and E.A. Balas Healthcare via cell phones: a systematic review Telemed J E Health 15 2009 231 240
100. L.K. Militello, S.A. Kelly, and B.M. Melnyk Systematic review of text-messaging interventions to promote healthy behaviors in pediatric and adolescent populations: implications for clinical practice and research Worldviews Evid Based Nurs 9 2012 66 77
101. M.S. Stockwell, E.O. Kharbanda, R.A. Martinez, C.Y. Vargas, D.K. Vawdrey, and S. Camargo Effect of a text messaging intervention on influenza vaccination in an urban, low-income pediatric and adolescent population: a randomized controlled trial JAMA 307 2012 1702 1708
102. M.S. Stockwell, E.O. Kharbanda, R.A. Martinez, M. Lara, D. Vawdrey, and K. Natarajan Text4Health: impact of text message reminder-recalls for pediatric and adolescent immunizations Am J Public Health 102 2012 15 21
103. T. Miloh, R. Annunziato, R. Arnon, J. Warshaw, S. Parkar, and F.J. Suchy Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging Pediatrics 124 2009 e844 e850
104. C.R. Ahlers-Schmidt, A.K. Chesser, A.M. Paschal, T.A. Hart, K.S. Williams, and B. Yaghmai Parent opinions about use of text messaging for immunization reminders J Med Internet Res 14 2012 e83
105. M.T. Britto, J.K. Munafo, P.J. Schoettker, A.L. Vockell, J.A. Wimberg, and M.S. Yi Pilot and feasibility test of adolescent-controlled text messaging reminders Clin Pediatr 51 2012 114 121
106. H. van Os-Medendorp, H. Koffijberg, P.C. Eland-de Kok, A. van der Zalm, M.S. de Bruin-Weller, and S.G. Pasmans E-health in caring for patients with atopic dermatitis: a randomized controlled cost-effectiveness study of internet-guided monitoring and online self-management training Br J Dermatol 166 2012 1060 1068
107. A.J. Watson, H. Bergman, C.M. Williams, and J.C. Kvedar A randomized trial to evaluate the efficacy of online follow-up visits in the management of acne Arch Dermatol 146 2010 406 411
108. B.A. Yentzer, A.A. Wood, M.J. Sagransky, J.L. O'Neill, A.R. Clark, and L.L. Williams An internet-based survey and improvement of acne treatment outcomes Arch Dermatol 147 2011 1223 1224
109. K. Vance, W. Howe, and R.P. Dellavalle Social internet sites as a source of public health information Dermatol Clin 27 2009 133 136
110. M. Migden, A. Chavez-Frazier, and T. Nguyen The use of high definition video modules for delivery of informed consent and wound care education in the Mohs surgery unit Semin Cutan Med Surg 27 2008 89 93
111. M. Deveau, and S. Chilukuri Mobile applications for dermatology Semin Cutan Med Surg 31 2012 174 182